证券代码：600679 900916 股票简称：上海凤凰 凤凰 B 股 编号：2026-002 上海凤凰企业（集团）股份有限公司 关于第三次挂牌转让闲置房产的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： ● 上海凤凰企业（集团）股份有限公司（以下简称上海凤凰、公司）于 2025 年 10 月 14 日、11 月 15 日分别披露了《上海凤凰关于预挂牌转让闲置房产的提 示性公告》（编号：2025-054）《上海凤凰关于第二次挂牌转让闲置房产的提示性 公告》（编号：2025-058），截至本公告披露日，首次挂牌后 1 套房产已成功转让， 第二次挂牌后 2 套房产被摘牌，本次将通过上海联合产权交易所（以下简称联交 所）对前两次挂牌剩余的 1 套房产进行公开挂牌转让。 ● 本次挂牌转让标的为前两次挂牌后剩余的 1 套房产，本次挂牌的房产首 次挂牌转让价格为 770 万元，第二次挂牌转让价格为 695 万元，第三次挂牌转让 价格为 695 万元，最终交易金额以实际成交价格为准。 ● 本次挂牌仍为信息披 ...

Core Viewpoint - Shanghai Phoenix (600679.SH) is conducting a public transfer of a remaining property after two previous listings, with the initial listing price set at 7.7 million yuan and subsequent listings at 6.95 million yuan [1] Group 1 - The property is being listed for transfer for the third time, with the final transaction amount to be determined based on the actual sale price [1] - The current listing is for information disclosure purposes and does not constitute a final transaction [1] - The counterparty for the transaction has not yet been determined, and no formal transaction contract has been signed, indicating a lack of clear performance arrangements [1]

Group 1 - The core point of the article is that Shanghai Phoenix (600679.SH) is announcing the transfer of a property that remains after two previous listings, with the initial listing price set at 7.7 million yuan and subsequent listings at 6.95 million yuan [1] - The current listing is still in the information disclosure phase and does not constitute a final transaction, as the trading counterpart has not been determined and no formal contract has been signed [1] - The final transaction amount will be based on the actual sale price, indicating that the pricing may vary depending on market conditions at the time of sale [1]

Core Insights - The children's scooter market in China is projected to reach a scale of 2.12 billion yuan in 2024, reflecting a year-on-year increase of 6.5% [1][3][8] - The industry is experiencing strong growth due to upgraded family consumption concepts and the popularity of outdoor activities for children [1][3] Industry Overview - Children's scooters, also known as toy scooters, are designed for children weighing up to 50 kg, enhancing balance and coordination skills [3][5] - The market is characterized by various types of scooters, categorized by wheel count (two, three, or four wheels) and weight groups (under 20 kg and 20-50 kg) [3][4] Market Dynamics - The industry is supported by a solid consumer base, with over 220 million children aged 0-14 in China, despite a 3.6% year-on-year decline in this population segment [5][6] - The upstream supply chain includes materials like aluminum alloy, plastic, and rubber, which are crucial for the quality and performance of scooters [6][7] Competitive Landscape - The market features a mix of international giants (e.g., Micro, Razor), domestic leaders (e.g., Goodbaby International, Zhonglu Co., Shanghai Phoenix), and emerging brands that drive innovation [9][10] - Goodbaby International reported a revenue of 4.301 billion yuan in the first half of the 2025 fiscal year, a 2.71% increase year-on-year, while its net profit decreased by 43.17% [10] - Shanghai Phoenix achieved a revenue of 1.835 billion yuan in the first nine months of 2025, a slight increase of 0.15%, with a significant net profit growth of 131.69% [10] Development Trends - The product evolution is moving towards multifunctionality and adaptability for various scenarios, with features like adjustable height and foldability being introduced [11][12] - Smart and eco-friendly innovations are becoming mainstream, incorporating features like tracking and speed control while using recyclable materials [11][12] - The sales model is shifting towards an omnichannel approach, integrating online and offline platforms to enhance consumer experience and brand differentiation [12]

Core Viewpoint - Shanghai Phoenix Enterprise (Group) Co., Ltd. is expected to achieve a net profit of approximately 120 million yuan for the year 2025, marking a turnaround from a loss in the previous year [2][4]. Financial Performance Forecast - The company anticipates a net profit attributable to shareholders of approximately 120 million yuan for the fiscal year 2025 [2][4]. - The net profit, after deducting non-recurring gains and losses, is projected to be around 62 million yuan [3][5]. Previous Year Comparison - In the previous year, the net profit attributable to shareholders was a loss of 139.09 million yuan, and the net profit after deducting non-recurring gains and losses was a loss of 63.52 million yuan [7]. - The basic earnings per share for the previous year were -0.27 yuan [8]. Reasons for Profit Turnaround - The main reasons for the expected profit turnaround include: - Focus on core business development, optimization of business structure, and continuous market expansion [9]. - Improvement in operational efficiency and strict cost control have contributed to steady growth in main business revenue and enhanced profitability [9]. - The absence of significant losses from non-recurring events, such as the fire incident affecting a subsidiary in the previous year, has also positively impacted the financial outlook [11].

Group 1 - The company, Shanghai Phoenix, announced an expected net profit of approximately 120 million yuan for the fiscal year 2025, attributed to the shareholders of the listed company [2]

Core Viewpoint - Shanghai Phoenix is expected to achieve a net profit of approximately 120 million yuan for the year 2025, marking a return to profitability compared to the previous year [1] Group 1: Financial Performance - The company anticipates a net profit attributable to shareholders of approximately 120 million yuan for 2025, indicating a significant improvement from the previous year's performance [1] - The main reason for the change in performance is the focus on core business development and optimization of business structure [1] Group 2: Business Strategy - The company has actively enhanced market expansion efforts and optimized production and operational efficiency [1] - Cost control measures have been strictly implemented, contributing to the overall improvement in profitability [1] Group 3: Revenue Growth - During the reporting period, the company's main business revenue has steadily increased, laying a solid foundation for the turnaround from loss to profit [1]

Earnings Forecasts - Shengyi Electronics expects a net profit of 1.431 billion to 1.513 billion yuan in 2025, an increase of 331.03% to 355.88% year-on-year [1] - Tigermed anticipates a net profit of 830 million to 1.23 billion yuan in 2025, representing a growth of 105% to 204% year-on-year [2] - Shunbo Alloy forecasts a net profit of 210 million to 270 million yuan in 2025, with an increase of 222.96% to 315.23% year-on-year [3] - Jinkong Electric expects a net profit of 155 million to 195 million yuan in 2025, reflecting a growth of 383.21% to 507.9% year-on-year [9] - Baiao Saitu anticipates a net profit of 162 million to 182 million yuan in 2025, with a year-on-year increase of 384.26% to 443.88% [18] - Panjiang Co. expects a net profit of 318 million to 380 million yuan in 2025, representing a growth of 205.30% to 264.83% year-on-year [38] Loss Forecasts - Liaoning Energy predicts a net loss of 273 million to 410 million yuan in 2025, compared to a profit of 202 million yuan in the previous year [5] - Anbotong anticipates a net loss of 114 million to 165 million yuan in 2025, with a revenue decrease of 19.65% to 27.25% [7] - Wantai Bio forecasts a net loss of 330 million to 410 million yuan in 2025, compared to a profit of 106 million yuan in the previous year [12] - Xingyun Co. expects a net loss of 155 million to 230 million yuan in 2025, compared to a loss of 82.44 million yuan in the previous year [20] - Huaxing Co. anticipates a net loss of 800 million to 1.2 billion yuan in 2025, with a reduction in loss compared to 1.67 billion yuan in the previous year [46] New Product Approvals - Hengrui Medicine received acceptance for a new indication application for its innovative drug, combining Carrelizumab and Apatinib for treating unresectable liver cancer [4] - Tianen Kang's subsidiary received a drug registration acceptance notice for Lidocaine and Prilocaine aerosol [31] - Lisheng Pharmaceutical announced that its Aminophylline tablets passed the consistency evaluation for generic drugs [40] Share Buyback Plans - Hengyuan Coal Power plans to repurchase shares with a total amount not less than 200 million yuan and not exceeding 250 million yuan [13] Contract Wins - China Communication Signal Co. won contracts totaling approximately 5.26 billion yuan for 21 important projects in the railway and urban rail transit markets [37]

Core Viewpoint - Shanghai Phoenix (600679.SH) forecasts a net profit attributable to shareholders of approximately 120 million yuan for the year 2025, indicating a return to profitability compared to the previous year [1] Group 1: Financial Performance - The company expects a net profit of around 120 million yuan for 2025, showing a significant improvement from the previous year's performance [1] - The main business revenue is steadily increasing, contributing to the company's enhanced profitability [1] Group 2: Business Strategy - The company is focusing on the development of its core business and actively optimizing its business structure [1] - Continuous efforts are being made to strengthen market expansion and improve production operational efficiency [1] - The company is implementing strict cost control measures to manage expenses effectively [1]

Core Viewpoint - Shanghai Phoenix (600679.SH) is expected to achieve a net profit of approximately 120 million yuan for the year 2025, marking a return to profitability compared to the previous year [1] Group 1: Financial Performance - The company anticipates a net profit attributable to shareholders of approximately 120 million yuan for 2025, indicating a positive change from the previous year's performance [1] - The main business revenue of the company is steadily increasing, contributing to the improvement in profitability [1] Group 2: Business Strategy - The company is focusing on the development of its main business and actively optimizing its business structure [1] - Continuous efforts are being made to enhance market expansion and optimize production and operational efficiency [1] - The company is implementing strict cost control measures to support its financial turnaround [1]